Cision Newshttps://news.cision.comCision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.Tue, 09 Jun 2026 16:11:52 GMTCision News14660https://news.cision.comhttps://news.cision.com/Content/img/news-logo.pngAnnual General Meeting in NattoPharma ASAhttps://news.cision.com/nattopharma-asa/r/annual-general-meeting-in-nattopharma-asa,c3366938cision3999535Mon, 14 Jun 2021 15:47:17 GMTNattoPharma ASA: Compagnie des Levures Lesaffre announces completion of compulsory acquisitionhttps://news.cision.com/nattopharma-asa/r/nattopharma-asa--compagnie-des-levures-lesaffre-announces-completion-of-compulsory-acquisition,c3363433cision3996295Wed, 09 Jun 2021 15:00:00 GMTNattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisitionhttps://news.cision.com/nattopharma-asa/r/nattopharma-asa--compagnie-des-levures-lesaffre-announces-compulsory-acquisition,c3363431cision3995586Wed, 09 Jun 2021 06:00:00 GMTNattoPharma ASA: Results of mandatory offer for all outstanding shares in NattoPharma ASAhttps://news.cision.com/nattopharma-asa/r/nattopharma-asa--results-of-mandatory-offer-for-all-outstanding-shares-in-nattopharma-asa,c3349279cision3976868Wed, 19 May 2021 06:00:49 GMTNattoPharma ASA: 90% threshold surpassedhttps://news.cision.com/nattopharma-asa/r/nattopharma-asa--90--threshold-surpassed,c3348743cision3976152Tue, 18 May 2021 10:20:00 GMTNattoPharma ASA: End of Offer Period for mandatory offer for all outstanding shares in NattoPharma ASAhttps://news.cision.com/nattopharma-asa/r/nattopharma-asa--end-of-offer-period-for-mandatory-offer-for-all-outstanding-shares-in-nattopharma-a,c3348746cision3976154Tue, 18 May 2021 10:20:00 GMTNattoPharma releases Q1 2021 Trading Updatehttps://news.cision.com/nattopharma-asa/r/nattopharma-releases-q1-2021-trading-update,c3343226cision3972386Wed, 12 May 2021 06:30:00 GMTAnnual Report 2020https://news.cision.com/nattopharma-asa/r/annual-report-2020,c3337503cision3961249Fri, 30 Apr 2021 05:26:11 GMTNattoPharma ASA: Lesaffre is launching mandatory offer for NattoPharmahttps://news.cision.com/nattopharma-asa/r/nattopharma-asa--lesaffre-is-launching-mandatory-offer-for-nattopharma,c3328779cision3948645Tue, 20 Apr 2021 05:45:00 GMTNattoPharma ASA: Compagnie des Levures Lesaffre completes settlement of option shareshttps://news.cision.com/nattopharma-asa/r/nattopharma-asa--compagnie-des-levures-lesaffre-completes-settlement-of-option-shares,c3323903cision3941714Mon, 12 Apr 2021 16:30:20 GMTMANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDERS AND CLOSE ASSOCIATEShttps://news.cision.com/nattopharma-asa/r/mandatory-notification-of-trade-by-primary-insiders-and-close-associates,c3316510cision3931647Mon, 29 Mar 2021 15:27:07 GMTDisclosure of large shareholdinghttps://news.cision.com/nattopharma-asa/r/disclosure-of-large-shareholding,c3316506cision3931625Mon, 29 Mar 2021 15:09:10 GMTNattoPharma ASA: Compagnie des Levures Lesaffre completes voluntary offer for all outstanding shares in NattoPharma ASAhttps://news.cision.com/nattopharma-asa/r/nattopharma-asa--compagnie-des-levures-lesaffre-completes-voluntary-offer-for-all-outstanding-shares,c3316012cision3931013Mon, 29 Mar 2021 08:26:33 GMTNew share capital registeredhttps://news.cision.com/nattopharma-asa/r/new-share-capital-registered,c3315787cision3930592Mon, 29 Mar 2021 06:02:15 GMTNattoPharma ASA: Final results of voluntary offer for all outstanding shares in NattoPharma ASAhttps://news.cision.com/nattopharma-asa/r/nattopharma-asa--final-results-of-voluntary-offer-for-all-outstanding-shares-in-nattopharma-asa,c3313303cision3927123Wed, 24 Mar 2021 11:45:04 GMTUpdate on acceptances – cash tender offer for all outstanding shares in Kaydence Pharma AS.https://news.cision.com/nattopharma-asa/r/update-on-acceptances---cash-tender-offer-for-all-outstanding-shares-in-kaydence-pharma-as-,c3312838cision3926423Tue, 23 Mar 2021 19:43:41 GMTNattoPharma ASA: Preliminary results of voluntary offer for all outstanding shares in NattoPharma ASA and fulfilment of closing conditionshttps://news.cision.com/nattopharma-asa/r/nattopharma-asa--preliminary-results-of-voluntary-offer-for-all-outstanding-shares-in-nattopharma-as,c3312835cision3926421Tue, 23 Mar 2021 19:39:33 GMTNattoPharma ASA: End of Offer Period for voluntary offer for all outstanding shares in NattoPharma ASAhttps://news.cision.com/nattopharma-asa/r/nattopharma-asa--end-of-offer-period-for-voluntary-offer-for-all-outstanding-shares-in-nattopharma-a,c3312668cision3926248Tue, 23 Mar 2021 14:51:45 GMTNattoPharma ASA is launching cash tender offer to acquire 100% of the shares of Kaydence Pharma AS at an offer price of NOK 5 per sharehttps://news.cision.com/nattopharma-asa/r/nattopharma-asa-is-launching-cash-tender-offer-to-acquire-100--of-the-shares-of-kaydence-pharma-as-a,c3302762cision3912481Tue, 09 Mar 2021 06:57:27 GMTNattoPharma ASA: Lesaffre is launching recommended voluntary cash offer for NattoPharma at NOK 35 per sharehttps://news.cision.com/nattopharma-asa/r/nattopharma-asa--lesaffre-is-launching-recommended-voluntary-cash-offer-for-nattopharma-at-nok-35-pe,c3302756cision3912478Tue, 09 Mar 2021 06:51:05 GMTContemplated voluntary cash offer by Lesaffre to acquire all shares in NattoPharmahttps://news.cision.com/nattopharma-asa/r/contemplated-voluntary-cash-offer-by-lesaffre-to-acquire-all-shares-in-nattopharma,c3298465cision3906240Tue, 02 Mar 2021 06:36:09 GMTMANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDERS AND DISCLOSURE OF LARGE SHAREHOLDINGhttps://news.cision.com/nattopharma-asa/r/mandatory-notification-of-trade-by-primary-insiders-and-disclosure-of-large-shareholding,c3298331cision3906094Mon, 01 Mar 2021 21:37:51 GMTMANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDERShttps://news.cision.com/nattopharma-asa/r/mandatory-notification-of-trade-by-primary-insiders,c3298329cision3906092Mon, 01 Mar 2021 21:34:52 GMTMANDATORY NOTIFICATION OF TRADE AND DISCLOSURE OF LARGE SHAREHOLDINGhttps://news.cision.com/nattopharma-asa/r/mandatory-notification-of-trade-and-disclosure-of-large-shareholding,c3297685cision3905477Mon, 01 Mar 2021 08:24:40 GMT